Yontus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 05-12-2024
- Paid Up Capital ₹ 1.20 Cr
as on 05-12-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.74 Cr
as on 05-12-2024
- Revenue 847.51%
(FY 2020)
- Profit 219.92%
(FY 2020)
- Ebitda 3305.71%
(FY 2020)
- Net Worth 2.93%
(FY 2020)
- Total Assets 29.43%
(FY 2020)
About Yontus Life Sciences
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.20 Cr.
The company currently has active open charges totaling ₹3.74 Cr.
Rihanaparveen Shaik and Bala Challa serve as directors at the Company.
- CIN/LLPIN
U24304AP2016PTC103065
- Company No.
103065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Yontus Life Sciences Private Limited offer?
Yontus Life Sciences Private Limited offers a wide range of products and services, including Inspection & Quality Check Services, Food Certification Services.
Who are the key members and board of directors at Yontus Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rihanaparveen Shaik  | Director | 12-Dec-2018 | Current |
| Bala Challa | Director | 06-Apr-2016 | Current |
Financial Performance of Yontus Life Sciences.
Yontus Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 847.51% increase. The company also saw a substantial improvement in profitability, with a 219.92% increase in profit. The company's net worth moved up by a moderate rise of 2.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yontus Life Sciences?
In 2019, Yontus Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ablicon Industries Private LimitedActive 5 years 11 monthsRihanaparveen Shaik and Bala Challa are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Aug 2021 | ₹4.95 M | Open |
Others Creation Date: 18 May 2021 | ₹5.00 M | Open |
Others Creation Date: 07 May 2021 | ₹5.40 M | Open |
How Many Employees Work at Yontus Life Sciences?
Unlock and access historical data on people associated with Yontus Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yontus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yontus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
